keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EGFR peptide (myristoylated), a synthetic peptide inhibitor of PKC (IC50 = 5 µM), corresponds to the intracellular region's amino acid sequence of EGFR. It effectively reverses doxorubicin resistance in UV-2237M (UV-2237M-ADRR) fibrosarcoma cells at a concentration of 1 µM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 105.00 | |
10 mg | Inquiry | $ 196.00 | |
50 mg | Inquiry | $ 790.00 | |
100 mg | Inquiry | $ 1,260.00 |
Description | EGFR peptide (myristoylated), a synthetic peptide inhibitor of PKC (IC50 = 5 µM), corresponds to the intracellular region's amino acid sequence of EGFR. It effectively reverses doxorubicin resistance in UV-2237M (UV-2237M-ADRR) fibrosarcoma cells at a concentration of 1 µM. |
Synonyms | Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH, Epidermal Growth Factor Receptor Peptide, N-myristoyl-RKRTLRRL |
Molecular Weight | 1308.71 |
Formula | C60H117N21O11.XCF3COOH |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS pH 7.2: 2 mg/ml
DMSO: 10 mg/ml
DMF: 10 mg/ml
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFR Peptide (human, mouse) (myristoylated) TFA Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH Epidermal Growth Factor Receptor Peptide N-myristoyl-RKRTLRRL inhibitor inhibit